Search Results: keywords:"direct-to-consumer drug advertising"

  • S. 4785 — To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.
    Status:Introduced in Senate
    Words:703

    S. 4785, titled the “Responsibility in Drug Advertising Act of 2024”, aims to amend the Federal Food, Drug, and Cosmetic Act to place restrictions on direct-to-consumer drug advertising. It prohibits advertising newly approved drugs to consumers for the first three years...

    Simple Explanation

    S. 4785 is a new rule that wants to stop ads about new medicines on TV or online for the first three years after they are allowed. But if the medicine is good for people's health, an exception can be asked for in the third year.

  • S. 483 — To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.
    Status:Introduced in Senate
    Words:709

    S. 483, titled the "Responsibility in Drug Advertising Act of 2025," seeks to amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising. The bill prohibits advertising a newly approved drug directly to consumers, including on social media...

    Simple Explanation

    S. 483 is a new rule that says companies can't show ads for new medicines on TV or the internet for the first three years they are available, but there might be a way to advertise sooner if it's important for people's health.